Arrowhead Pharmaceuticals D
D
ARWR
66.510
USD
-1.22
(-1.80%)
مغلق
حجم التداول
67,366
الربح لكل سهم
-3
العائد الربحي
-
P/E
-29
حجم السوق
9,394,834,600
العنوان: Arrowhead Pharmaceuticals
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.